Aspirin effects in alcoholics
This article was originally published in The Tan Sheet
Executive Summary
McNeil's data submission to the Nonprescription Drugs Advisory Committee on upper gastrointestinal tract bleeding associated with aspirin use in heavy drinkers is now publicly available in FDA's docket covering the rulemaking for OTC internal analgesic, anitpyretic and antirheumatic drug products at the request of the Aspirin Foundation of America ("The Tan Sheet" Aug. 2, In Brief). The advisory committee is scheduled to consider the issue at a Sept. 8-9 meeting. A request by AFA to delay the meeting until December was denied by FDA in an Aug. 11 letter.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning